Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Food Encapsulation Market Size & Share 2026-2035
Report ID: GMI1203
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Food Encapsulation Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Food Encapsulation Market Size
The Food Encapsulation Market was valued at USD 13.80 billion in 2025, is projected to reach USD 14.90 billion in 2026, and is expected to grow at an 8.00% CAGR (2026–2035) to USD 29.79 billion by 2035. The market comprises commercial systems that protect, stabilize, mask, or control the release of active ingredients used in food, beverage, dietary supplement, infant nutrition, and clinical nutrition formulations.
Food Encapsulation Market Key Takeaways
Market Leader: Kerry Group PLC led with over 6.50% market share in 2025.
Leading Players: Top 5 players in this market include Kerry Group PLC, DSM-Firmenich, IFF (International Flavors & Fragrances), Givaudan SA, Balchem Corporation, which collectively held a market share of 23.50% in 2025.
The food encapsulation market is moving from a specialist processing capability toward a core formulation discipline. Demand is being shaped by the need to preserve sensitive actives through processing and storage while allowing manufacturers to formulate fortified products without compromising taste, appearance, or shelf-life performance. This favors suppliers able to combine shell-material science, process control, and application-specific technical support.
GMI Analyst View
Based on input from industry leaders, the market reached 1,000 kilotons in global volume in 2025. We view this scale as evidence that encapsulated systems have become embedded in mainstream ingredient supply chains, with the next phase of value creation depending less on basic throughput and more on the sophistication of protected bioactive delivery.
Food Encapsulation Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is increasingly concentrated in formulations where stability, sensory masking, and controlled release are commercially decisive, particularly for probiotics and nutritional lipids. At the same time, high equipment costs and uneven regulatory treatment of advanced delivery systems keep adoption selective in lower-margin food categories and regulated markets.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Probiotic delivery is a direct source of demand because viable cultures must withstand thermal processing, moisture, oxygen exposure, and gastric conditions before they can deliver their intended functional benefit. The global probiotic supplements market reached US$9.0 billion in 2023 [1]International Probiotics Association. "Global Analysis of Probiotic Data 2024." ipa-biotics.org. This creates an attractive addressable base for encapsulation suppliers that can demonstrate reliable viability outcomes across beverage, dairy, and supplement formats while retaining scalable production economics.
Nutritional lipid fortification also rewards technically differentiated delivery systems. EPA and DHA ingredients require protection from oxidation and sensory control when incorporated into aqueous or dairy-based products. The global EPA and DHA omega-3 ingredient market was valued at USD 2,379.7 million in 2024 [2]Nutrition Insight / GOED. "Global EPA and DHA omega-3 supply chain is in recovery, says GOED analysis." nutritioninsight.com. As fortification moves into more everyday formats, suppliers with water-dispersible lipid systems and strong application support are positioned to capture greater value per formulation.
Natural shell materials are becoming more central to portfolio design, not merely to ingredient sourcing. Polysaccharides and proteins can help manufacturers reconcile clean-label objectives with moisture protection, film formation, and release control. The commercial opportunity therefore lies in reproducing the functional reliability of legacy systems while meeting more demanding label and sustainability specifications.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Capital intensity remains a structural constraint because commercial-scale spray drying, fluid-bed coating, controlled-atmosphere handling, and analytical quality assurance must operate as an integrated system. Research on bioactive encapsulation identifies production cost as a material adoption barrier [3]National Center for Biotechnology Information. "Bioactive compound encapsulation: Characteristics, applications in food systems, and implications for human health." pmc.ncbi.nlm.nih.gov. This makes toll manufacturing and integrated specialty-ingredient platforms important routes to market for brands that lack their own process infrastructure.
The same cost logic limits penetration in commodity food categories. Encapsulation adds shell material, processing energy, yield-management, and validation costs, while many high-volume food formats have limited ability to absorb a formulation premium. Suppliers therefore need to demonstrate a specific commercial return, such as longer shelf life, differentiated nutrition claims, or more consistent process performance.
Regulatory uncertainty creates an additional challenge for nanoscale delivery systems. Reviews of food-related nanoencapsulation highlight the need for careful safety and regulatory assessment [4]National Center for Biotechnology Information. "Nanoencapsulated Essential Oils for Post-Harvest Preservation of Stored Cereals: A Review." pmc.ncbi.nlm.nih.gov. Companies commercializing advanced systems must therefore balance the performance advantages of smaller particle architectures against country-by-country approval complexity and a potentially longer route to market.
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
GMI Analyst View
We see the forecast increasingly shaped by a value-mix shift rather than by a simple expansion in ingredient volumes. Premium delivery systems for sensitive bioactives can raise the commercial importance of formulation performance, but the pace of that transition will depend on whether regulatory clarity and process efficiency improve quickly enough to broaden adoption beyond specialist applications.
Food Encapsulation Market Segment Analysis
By Technology
Microencapsulation accounted for a 68.00% revenue share in 2025 and is projected to reach USD 18.47 billion by 2035. The Food Encapsulation Market continues to rely on this technology because spray drying, fluid-bed coating, extrusion, spray chilling, and freeze drying can serve a broad range of ingredients and food formats at established commercial scale. Its leadership reflects process familiarity, wide material compatibility, and a large installed manufacturing base.
Nanoencapsulation generated USD 1.38 billion in 2025 and is expected to expand at a 12.5% CAGR (2026–2035). Its appeal lies in applications where dispersion stability, bioavailability, and optical clarity are decisive, especially for functional beverages and lipid-based actives. Commercial adoption will depend on suppliers translating laboratory-scale performance into validated, cost-effective, and regulatorily acceptable food systems.
Emulsion-Based Encapsulation generated USD 1.79 billion in 2025 and is forecast to grow at an 8.8% CAGR (2026–2035). Double emulsions, multiple emulsions, and particle-stabilized formats provide a flexible route for lipid protection and controlled ingredient release. Demand is supported by dairy, dressing, and beverage formulators seeking clean-label approaches to stabilize sensitive oils and flavor systems.
Coacervation is projected to reach USD 1.49 billion by 2035 and held a 5.00% revenue share in 2025. The technology remains particularly relevant where high payload capacity and controlled flavor release are required. Its continued role in confectionery, flavor, enzyme, and probiotic applications reflects the ability of coacervate shells to address demanding release and protection requirements.
Liposome Entrapment generated USD 0.41 billion in 2025 and is forecast to expand at an 8.1% CAGR (2026–2035). Phospholipid bilayers are valuable in applications requiring biocompatible delivery of vitamins, minerals, and nutritional lipids. The technology's commercial position is strongest in high-value nutrition products where validated delivery performance outweighs greater formulation complexity.
By Shell Material
Polysaccharides held a 42.00% revenue share in 2025 and are forecast to grow at a 7.5% CAGR (2026–2035). Starch, modified starch, maltodextrin, gum arabic, alginate, and pectin remain foundational to commercial food encapsulation because they combine scale availability with film-forming and moisture-management properties. Their versatility supports continued use across spray-dried flavors, vitamins, and functional powders.
Proteins are projected to reach USD 8.34 billion by 2035 and are expected to grow at an 8.4% CAGR (2026–2035). Whey, casein, soy, and plant proteins offer both clean-label relevance and useful interfacial behavior, making them well suited to emulsions and sensitive bioactive systems. Their adoption will be reinforced where manufacturers need shell materials that align with natural-positioning strategies without sacrificing technical performance.
Lipids generated USD 3.04 billion in 2025 and are forecast to expand at an 8.5% CAGR (2026–2035). Edible waxes, fatty acids, and phospholipids are important where high-temperature stability, moisture-triggered release, or lipid-compatible protection is required. Their role in bakery, confectionery, and lipid nanoparticle applications makes this category increasingly important as controlled-release specifications become more sophisticated.
Emulsifiers are projected to reach USD 2.09 billion by 2035 and held a 7.00% revenue share in 2025. Lecithin and mono- and diglycerides principally act as interfacial stabilizers rather than stand-alone wall materials. Their market position is therefore linked closely to the expansion of emulsion and nanoemulsion systems rather than to conventional dry-powder encapsulation.
By Core Material
Vitamins & Minerals generated USD 3.73 billion in 2025 and are projected to reach USD 7.45 billion by 2035. This segment remains a durable volume base because micronutrients are vulnerable to light, oxygen, processing stress, and ingredient interactions. Encapsulation allows fortified foods, infant nutrition, and supplement products to protect potency while managing undesirable sensory effects.
Probiotics & Prebiotics are projected to reach USD 7.45 billion by 2035 and held a 22.00% revenue share in 2025. Commercial probiotic delivery depends on preserving viability from manufacturing through consumption, which makes encapsulation a core product specification rather than an optional enhancement. Suppliers with strong strain-specific validation and scalable coating capabilities are especially well placed in this segment.
Flavors & Essences generated USD 3.04 billion in 2025 and are expected to hold a 20.00% revenue share in 2035. Flavor encapsulation continues to serve bakery, confectionery, and savory food innovation by protecting volatile compounds and enabling controlled sensory release. The segment's outlook is tied to new product-development activity and demand for natural flavor systems that maintain performance under processing and storage conditions.
Nutritional Lipids are projected to reach USD 3.87 billion by 2035 and held a 10.00% revenue share in 2025. Omega-3 ingredients are the principal source of demand because their oxidation sensitivity and characteristic sensory profile make direct formulation difficult. Encapsulation enables wider use in infant formula, dairy, beverages, and nutrition products where stability and consumer acceptance must be managed simultaneously.
Enzymes generated USD 0.97 billion in 2025 and are forecast to grow at an 8.0% CAGR (2026–2035). Encapsulation allows processors to separate enzyme activity from the stages of manufacturing where it would be premature or disruptive. This supports applications in breadmaking, cheese production, and meat processing, where release timing can influence consistency and process control.
Colors & Pigments are projected to reach USD 1.79 billion by 2035 and held a 7.00% revenue share in 2025. Natural colorants often require protection from light, heat, and oxidation, making encapsulation important to formulation reliability. The segment benefits from reformulation activity as manufacturers seek stable natural alternatives across beverage, dairy, and confectionery products.
Sweeteners & Preservatives generated USD 0.41 billion in 2025 and are forecast to grow at an 8.1% CAGR (2026–2035). Controlled release can improve the handling of acids, leavening systems, and preservation ingredients in processing environments. Its value is most apparent where reaction timing and shelf-life stability affect manufacturing yields or finished-product consistency.
By Application
Functional & Fortified Foods generated USD 3.73 billion in 2025 and are forecast to grow at a 7.2% CAGR (2026–2035). This application benefits from consumer demand for nutrition-led everyday food formats, including cereals, snacks, spreads, and bars. Encapsulation gives manufacturers a practical way to add sensitive actives without compromising organoleptic performance.
Dietary Supplements & Nutraceuticals generated USD 3.04 billion in 2025 and are projected to reach USD 7.45 billion by 2035. Supplement products can support the added cost of controlled-release beads, coated powders, and protected bioactive systems because delivery performance is central to their commercial proposition. This makes the application a high-value outlet for omega-3, probiotic, vitamin, and botanical ingredient systems.
Bakery & Confectionery generated USD 2.48 billion in 2025 and are projected to reach USD 5.06 billion by 2035. Encapsulated leavening agents, acids, colors, and flavors provide processing flexibility and help manufacturers achieve more consistent finished-product quality. Demand is supported by the need to manage release timing through baking and maintain sensory performance in complex confectionery formats.
Dairy & Frozen Desserts are expected to hold an 11.00% revenue share in 2035 and are forecast to grow at a 7.0% CAGR (2026–2035). Probiotic fortification, vitamin delivery, and omega-3 inclusion make dairy systems an important testing ground for ingredient protection. Suppliers must balance stability with dispersion and texture requirements in products that can be sensitive to processing and storage conditions.
Beverages generated USD 1.38 billion in 2025 and are projected to reach USD 3.28 billion by 2035. The application is technically demanding because aqueous systems impose challenges involving pH, transparency, dispersion, and thermal treatment. Nanoemulsions and other advanced delivery systems are gaining relevance where manufacturers need to preserve both functional performance and a clear consumer-facing product appearance.
Infant & Clinical Nutrition are expected to hold a 7.00% revenue share in 2035 and are forecast to grow at a 9.7% CAGR (2026–2035). These applications demand stringent control over stability, safety, and bioavailability, positioning encapsulation as an enabler of product compliance and performance. Protected delivery of nutritional lipids, iron, vitamins, and probiotics is particularly relevant in premium nutrition formulations.
Convenience & Processed Foods held a 4.00% revenue share in 2025 and are projected to reach USD 0.89 billion by 2035. Adoption remains selective because formulation benefits must offset the cost premium in categories with limited margin flexibility. Encapsulation is most likely to expand in premium products where flavor protection, longer shelf life, or nutrition claims create a clear commercial return.
GMI Analyst View
We view the segment mix as a transition from a broad base of established vitamin, mineral, and flavor protection toward more technically demanding bioactive delivery. The strategic question is whether cost improvements in established processes and broader sourcing of natural shell materials will allow premium encapsulation capabilities to diffuse into mid-tier food and beverage applications.
Food Encapsulation Market Regional Analysis
North America Food Encapsulation Market Analysis
North America generated USD 4.28 billion in 2025 and is projected to reach USD 6.85 billion by 2035. The Food Encapsulation Market in the region is supported by a mature specialty-ingredient industry, established encapsulation infrastructure, and demand from functional food, dietary supplement, and fortified beverage manufacturers. Growth is increasingly tied to technology upgrades and premium applications rather than broad penetration into lower-margin food categories.
United States
The United States generated USD 3.73 billion in 2025 and is forecast to grow at a 4.5% CAGR (2026–2035). Demand is anchored in dietary supplements, probiotic dairy, fortified beverages, and specialty bakery systems. The market's maturity favors suppliers that can improve performance, regulatory support, and formulation efficiency for existing customer applications.
Canada
Canada is projected to reach USD 1.04 billion by 2035 and is forecast to expand at a 6.6% CAGR (2026–2035). Functional foods, nutraceuticals, infant nutrition, and omega-3-enriched dairy offer important demand channels. The country provides growth opportunities for suppliers able to combine targeted technical support with compliant nutrition-led ingredient systems.
Europe Food Encapsulation Market Analysis
Europe is expected to hold a 23.00% revenue share in 2035 and is forecast to grow at a 6.3% CAGR (2026–2035). The region's market is shaped by rigorous ingredient standards, a strong clean-label orientation, and a deep base of food technology and flavor specialists. Demand is concentrated in systems that can demonstrate performance while supporting natural-carrier and product-transparency objectives.
Germany
Germany generated USD 0.97 billion in 2025 and is expected to hold a 5.50% revenue share in 2035. Its specialist ingredient base and advanced food-processing infrastructure support demand for flavor, enzyme, vitamin, and carotenoid delivery systems. Germany remains a significant production and innovation center for suppliers serving European food and nutrition customers.
United Kingdom
The United Kingdom held a 6.00% revenue share in 2025 and is forecast to grow at a 6.0% CAGR (2026–2035). Dietary supplements and functional beverages provide a strong commercial base for protected probiotic and nutritional-lipid ingredients. Market development depends on suppliers adapting technical platforms to the needs of retail-led innovation and fast-moving nutrition brands.
France
France is projected to reach USD 1.19 billion by 2035 and held a 5.00% revenue share in 2025. Flavor protection in bakery and confectionery remains important, while probiotic dairy and functional beverage development provide additional avenues for growth. The market favors formulation systems that can preserve sensory quality alongside active-ingredient stability.
Asia Pacific Food Encapsulation Market Analysis
Asia Pacific is projected to reach USD 10.13 billion by 2035 and is forecast to expand at a 10.5% CAGR (2026–2035). The Food Encapsulation Market is supported by expanding functional food, dietary supplement, dairy, infant formula, and fortified beverage demand. Growing local manufacturing capability and nutrition-focused consumer demand make the region central to the industry's future supply-chain and product-development strategy.
China
China generated USD 1.52 billion in 2025 and is forecast to grow at a 10.6% CAGR (2026–2035). Probiotic dairy, dietary supplements, and infant-formula quality requirements support demand for protected bioactive ingredients. Companies seeking scale must align formulation capabilities with local procurement needs and evolving nutrition standards.
Japan
Japan held a 5.00% revenue share in 2025 and is projected to reach USD 1.34 billion by 2035. Its established functional-food environment supports technically validated ingredient delivery systems, particularly in probiotic dairy and functional beverages. The market rewards consistent performance, credible health positioning, and high-quality application support.
South Korea
South Korea generated USD 0.41 billion in 2025 and is expected to hold a 2.50% revenue share in 2035. Demand is supported by a sophisticated functional-food and supplement market, including probiotic and collagen-peptide formulations. Innovation-led consumer demand creates room for differentiated encapsulated bioactive systems.
India
India is projected to reach USD 2.09 billion by 2035 and is forecast to expand at a 14.3% CAGR (2026–2035). Expanding supplement distribution, fortified staple-food programs, dairy development, and rising consumer purchasing power create multiple demand channels. Suppliers that can offer cost-conscious solutions and establish local processing or technical partnerships are likely to benefit most.
Latin America Food Encapsulation Market Analysis
Latin America generated USD 1.24 billion in 2025 and is forecast to grow at a 10.2% CAGR (2026–2035). Functional dairy, fortified foods, and dietary supplements are broadening the market's demand base, while local spray-drying and toll-processing investment improves access to encapsulation capacity. The region's opportunity depends on translating premium nutrition concepts into products suited to mass-market channels.
Brazil
Brazil generated USD 0.55 billion in 2025 and is forecast to grow at a 9.3% CAGR (2026–2035). Its large food and beverage industry, probiotic dairy market, and expanding functional-food presence underpin demand. A clearer pathway for functional ingredient development helps strengthen the country's appeal as a regional production and commercialization base.
Mexico
Mexico is projected to reach USD 1.04 billion by 2035 and held a 3.00% revenue share in 2025. The market benefits from demand for fortified beverages, supplements, and processed-food innovation. Givaudan expanded encapsulation production capacity at its Pedro Escobedo facility in 2024, highlighting the strategic relevance of the country to regional ingredient supply [5]Givaudan. "Givaudan expands its production capacity for encapsulation technologies in Pedro Escobedo, Mexico." givaudan.com.
Middle East & Africa Food Encapsulation Market Analysis
Middle East & Africa is expected to hold a 9.00% revenue share in 2035 and is forecast to grow at a 12.4% CAGR (2026–2035). Growth is supported by food-manufacturing modernization, supplement demand, and rising interest in fortified and infant nutrition products. The region presents a growing opportunity for suppliers that can navigate import-led distribution models while developing localized technical and production capabilities.
Saudi Arabia
Saudi Arabia generated USD 0.28 billion in 2025 and is expected to hold a 2.50% revenue share in 2035. Demand is supported by functional food and supplement imports alongside investment in domestic food manufacturing. The market offers potential for suppliers that can support localization objectives and build reliable ingredient-service networks.
United Arab Emirates
The United Arab Emirates is projected to reach USD 0.74 billion by 2035 and held a 2.00% revenue share in 2025. Its role as a regional distribution and re-export hub supports demand for premium nutrition and functional-food ingredients. Commercial success depends on supplier access to sophisticated retail, hospitality, and cross-border distribution channels.
South Africa
South Africa generated USD 0.14 billion in 2025 and is forecast to expand at a 7.9% CAGR (2026–2035). Its relatively developed food industry and active supplement market support demand for probiotic dairy and fortified staple-food systems. The country provides a practical entry point for suppliers seeking broader sub-Saharan distribution opportunities.
GMI Analyst View
We expect regional expansion to reshape how encapsulation suppliers configure manufacturing, technical service, and sourcing. Growth markets will not reward technology alone: local regulatory navigation, access to appropriate shell materials, and proximity to fast-growing nutrition customers are becoming more consequential competitive variables.
Food Encapsulation Market Share & Competitive Landscape
The Food Encapsulation Market share landscape is fragmented, with competitive advantage determined by process depth, application specialization, ingredient integration, and geographic reach rather than by a single dominant supplier. Companies are competing through proprietary delivery platforms, natural-shell expertise, customer formulation support, and investments that increase capacity for high-value powders, flavors, and nutrition systems.
Kerry Group PLC held a 6.50% revenue share in 2025. Its Encapsulation & Delivery Systems capabilities sit within a broader Taste & Nutrition platform, allowing the company to combine flavor, nutrition, and delivery-system development for food, beverage, and supplement customers. This integrated positioning is valuable where customers seek a single supplier for sensory design and active-ingredient protection.
DSM-Firmenich held a 6.00% revenue share in 2025. The company's portfolio spans encapsulated vitamins, carotenoid systems, probiotics, flavors, and functional blends. Its competitive position rests on its ability to pair formulation science with global nutrition and flavor capabilities, particularly in applications where high-value actives require reliable process performance.
IFF (International Flavors & Fragrances) held a 4.00% revenue share in 2025. IFF's food encapsulation activities are embedded across flavor, texture, enzyme, and bioactive platforms. Its broad ingredient portfolio supports cross-selling opportunities where customers require emulsion-based, spray-dried, or controlled-release systems alongside wider food and beverage formulation support.
Givaudan SA held a 3.50% revenue share in 2025. The company combines encapsulation capabilities with its Taste & Wellbeing franchise, positioning it strongly in flavor and bioactive delivery. Its production expansion in Mexico reinforces the importance of regional capacity and shorter supply chains for serving Latin American food and beverage customers [5]Givaudan. "Givaudan expands its production capacity for encapsulation technologies in Pedro Escobedo, Mexico." givaudan.com.
Balchem Corporation held a 3.50% revenue share in 2025. Through its Shure Brands portfolio, the company focuses on encapsulated leavening agents, acidulants, and specialty systems used in bakery, confectionery, and meat processing. Its specialization in controlled reaction timing gives it a focused competitive position in process-sensitive food applications.
Cargill, Incorporated serves food, beverage, and nutrition customers through flavor encapsulation and emulsion capabilities. Its wider ingredient footprint enables the company to support customers seeking integrated systems that combine encapsulation with texturizing, sweetening, and formulation expertise.
BASF SE retains a conditional role in the market through microencapsulated vitamins and carotenoid beadlets following the divestiture of its Food & Health Performance Ingredients business. Its remaining presence is concentrated in established micronutrient-delivery systems rather than a broad encapsulation portfolio.
Ingredion Incorporated markets its CAPSUL® range for flavor and starch-based delivery applications. Its strength lies in starch and clean-label formulation expertise, which is increasingly relevant as food manufacturers seek naturally positioned encapsulant systems.
Tate & Lyle PLC provides modified starches and maltodextrins used in encapsulation-grade ingredient systems. Its specialty food ingredients focus supports participation in shell-material demand, particularly where customers prioritize functional performance and label transparency.
Symrise AG operates the evocore® platform for flavor and bioactive delivery. Its capabilities in coacervation, spray drying, and fluid-bed coating support a differentiated role in sensory-led food and beverage applications.
Roquette Freres supplies starch- and pea-protein-based systems relevant to food encapsulation. Its plant-based material expertise positions the company well as manufacturers look for shell materials that align with clean-label and alternative-protein product strategies.
Glanbia PLC operates the NutraShield® microencapsulation platform for vitamins, minerals, and bioactives. Its nutrition focus makes it particularly relevant to dietary supplement and functional-food customers seeking protected active delivery.
Sensient Technologies incorporates encapsulation within its color and flavor delivery systems. Its value proposition is strongest where natural colorants and flavor ingredients need protection against heat, light, or other formulation stresses.
TasteTech Ltd specializes in controlled-release food ingredient systems for bakery, confectionery, and savory applications. Its custom-formulation orientation gives it a differentiated role in applications where ingredient timing directly affects product quality and manufacturing performance.
Aveka Group provides contract encapsulation and particle-engineering services using spray drying, fluid-bed processing, and micro-spray coating. Its toll-manufacturing model offers a route to market for customers that need specialized processing without dedicated capital investment.
Advanced BioNutrition Corp focuses on probiotic encapsulation and survival performance through gastrointestinal conditions. Its specialization supports demand from food, beverage, and supplement customers for viable culture delivery systems.
Blue California operates the FineCap™ platform for natural bioactive delivery, including vitamins, polyphenols, and functional lipids. Its focus on natural ingredient systems aligns with growing demand for differentiated, label-conscious nutrition solutions.
Recent Industry Developments
dsm-firmenich, June 2025. dsm-firmenich broke ground on a Parma, Italy, production facility that will include an encapsulation line for concentrated powder flavors and functional blends. The project is designed to expand regional production capabilities for food and nutrition customers and is scheduled for completion in 2027 [6]dsm-firmenich. "dsm-firmenich breaks ground on new state-of-the-art production facility for the development of flavors and functional blends in Parma, Italy." our-company.dsm-firmenich.com.
Balchem Corporation, December 2025. Balchem announced a new high-capacity microencapsulation facility in Orange County, New York. The planned site is expected to support expanded production of its encapsulated food ingredient portfolio when it opens in 2027 [7]Balchem Corporation. "Balchem Announces New Microencapsulation Manufacturing Facility." balchem.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →